<add><doc>
	<field name = "DATE">31-MAR-1987 13:43:45.71</field>
	<field name = "PLACES">usa</field>
	<field name = "UNKNOWN">F
f2052reute
r f BC-IMMUNEX-IMNX>-GETS-F   03-31 0105</field>
	<field name = "TITLE">IMMUNEX IMNX> GETS FDA OKAY FOR HUMAN TESTS</field>
	<field name = "DATELINE">SEATTLE, March 31 -</field>
	<field name = "BODY">Immunex Corp said it received Food and
Drug Administration approval to begin human clinical testing of
a protein as a possible treatment for cancer.
    The company said the protein, granulocyte-macrophage colony
stimulating factor, stimulates production of white blood cells
essential to the body's immune function. It said it is
developing the compound with Behringwerke AG>, a subsidiary of
Hoechst AG.
    Immunex said the drug's potential applications include
restoration of white blood cell function, destruction of tumor
cells, and as an AIDS treatment.
 Reuter</field>
</doc></add>
